SAGE Publishing and The Foundation for Gender-Specific Medicine Publish Gender and the Genome
Los Angeles, CA (July 20, 2018) SAGE Publishing today announces a partnership with The Foundation for Gender-Specific Medicine to publish Gender and the Genome. A peer-reviewed, open access publication, the journal examines ways in which biological sex influences new science of the 21st century, particularly in the areas of technology and human life.
Comprised of original research, reviews, and commentaries, Gender and the Genome covers topics such as:
- Sex-specific differences in genomic, cellular, tissue, and whole animal function
- New life forms generated by synthetic biology
- Technological advances meant to enhance the function in humans
- Manufacture and usefulness of robotic devices
- Commentaries by ethicists, theologians, anthropologists, epidemiologists, and sociologists/social scientists on the achievements of 21st century science
The journal integrates the pivotal scientific developments of gender-specific medicine and the interpretation of the human genome. With an editorial board of renowned scholars from around the globe, Gender and the Genome engages the community of molecular biologists, engineers, ethicists, anthropologists, and legal experts in a dialogue about the nature and implications of 21st century technology.
The journal is also the official publication of the International Society for Gender Medicine and The Israeli Society for Gender-and Sex Conscious Medicine. It is supported in part by a grant from Isobel and Marvin Slomowitz. For more information, please visit the website for Gender and the Genome.
# # #
Sara Miller McCune founded SAGE Publishing in 1965 to support the dissemination of usable knowledge and educate a global community. SAGE is a leading international provider of innovative, high-quality content publishing more than 1,000 journals and over 800 new books each year, spanning a wide range of subject areas. Our growing selection of library products includes archives, data, case studies and video. SAGE remains majority owned by our founder and after her lifetime will become owned by a charitable trust that secures the company’s continued independence. Principal offices are located in Los Angeles, London, New Delhi, Singapore, Washington, D.C. and Melbourne. www.sagepublishing.com
Founded in 2006 as a continuation of the Partnership for Gender-Specific Medicine at Columbia University, The Foundation for Gender-Specific Medicine, Inc. (FGSM) was established in response to the new interest in the direct investigation of women’s health that began in the early 1990’s and which revealed that the differences between men and women were not only completely unexpected but more than had been even imagined and involved every organ in the body. As the first studies began to be published, it became apparent that men could not be considered normative for the entire human race, but that direct testing of both sexes was necessary for an accurate view of not only normal physiology but of the sex-specific experience of the disease. A new science of gender-specific medicine emerged and
continues to expand. Gender-specific medicine is not the study of women’s health; it is the study of ways in which biological sex and gender impact normal human function and the differences in men’s and women’s experience of disease. Go to gendermed.org/ for more information.
Marianne J. Legato, MD, Ph. D. (hon. c.), FACP is an internationally renowned academic, physician, author, lecturer, and pioneer in the field of gender-specific medicine. She is a Professor Emerita of Clinical Medicine at Columbia University College of Physicians & Surgeons and an Adjunct Professor of Medicine at Johns Hopkins Medical School. Dr. Legato is also the Director of the Foundation for Gender-Specific Medicine, which she founded in 2006 as a continuation of her work with The Partnership for Gender-Specific Medicine at Columbia University. She received an honorary PhD from the University of Panama in 2015 for her work on the differences between men and women.
At its core, gender-specific medicine is the science of how normal human biology differs between men and women and how the diagnosis and treatment of disease differs as a function of gender. Dr. Legato’s discoveries and those of her colleagues have led to a personalization of medicine that assists doctors worldwide in understanding the difference in normal function of men and women and in their sex-specific experiences of the same diseases.
She began her work in gender-specific medicine by authoring the first book on women and heart disease, The Female Heart: The Truth About Women and Coronary Artery Disease, which won the Blakeslee Award of the American Heart Association in 1992. Because of this research, the cardiovascular community began to include women in clinical trials affirming the fact that the risk factors, symptoms, and treatment of the same disease can be significantly different between the sexes. Convinced that the sex-specific differences in coronary artery disease were not unique, Dr. Legato began a wide-ranging survey of all medical specialties and in 2004, published the first textbook on gender-specific medicine, The Principles of Gender-Specific Medicine. The second edition appeared in 2010 and the third edition, dedicated to explaining how gender impacts biomedical investigation in the genomic era, won the PROSE Award in Clinical Medicine from the Association of American Publishers in 2018. A fourth edition is forthcoming.
She also founded the first scientific journals publishing new studies in the field, The Journal of Gender-Specific Medicine, and a newer version, Gender Medicine, both listed in the Index Medicus of the National Library of Medicine. She has founded a third peer-reviewed, open access journal, Gender and the Genome, which focuses on the impact of biological sex on technology and its effects on human life.
Dr. Legato is the author of multiple works, including: What Women Need to Know (Simon & Schuster, 1997), Eve’s Rib (Harmony Books, 2002), Why Men Never Remember and Women Never Forget (Rodale, 2005), Why Men Die First (Palgrave, 2008), The International Society for Gender Medicine: History and Highlights (Academic Press, 2017), and most recently, The Plasticity of Sex (Academic Press, 2020). Her books have been translated into 28 languages to date.
As an internationally respected authority on gender medicine, Dr. Legato has chaired symposia and made keynote addresses to world congresses in gender-specific medicine in Berlin, Israel, Italy, Japan, Panama, South Korea, Stockholm, and Vienna. In collaboration with the Menarini Foundation, she is co-chairing a symposium on epigenetics, Sex, Gender and Epigenetics: From Molecule to Bedside, to be held in Spring 2021 in Italy. She maintains one of the only gender-specific private practice in New York City, and she has earned recognition as one of the “Top Doctors in New York.”
